{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T05:48:44Z","timestamp":1791438524216,"version":"4.3.3"},"reference-count":40,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2020,11,29]],"date-time":"2020-11-29T00:00:00Z","timestamp":1606608000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Recent studies suggest that cutaneous melanoma mortality rates in Spain are stabilizing and even decreasing in younger cohorts.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>To analyse mortality rates of melanoma from the last 40\u00a0years, focusing on changes related with the development of new therapeutic approaches.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Death records and mid\u2010year population data were collected from the National Statistics Institute. By using the direct method, age\u2010standardized mortality rates were calculated for overall population and for each sex and age group. Significant changes in mortality trends were identified by Joinpoint regressions. The independent effects of age, period and cohort (APC) and potential years of life lost (PYLL) due to melanoma were also analysed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Age\u2010standardized melanoma mortality rates rose in Spain from 0.78 to 2.13 deaths per 100\u00a0000 from the first to the last quinquennium of the study (1979\u20131983 to 2014\u20132018) for the overall population. After a marked increase until 1995, mortality rates levelled off. Following this stabilization, from 2015 to 2018 there was a decrease in mortality rates for the overall population (average annual per cent change (AAPC): \u22124.3, not significant), more accused in males over 64\u00a0years old (yo). A period effect was observed from the beginning of 21st century, with mortality rates dropping to date.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>There is a decrease in melanoma mortality rates from 2015 in all age groups that confirms previous trends in mortality in younger cohorts. Improvement in diagnosis and development of new therapies for advanced melanoma may have a crucial role in this event. Close monitoring of melanoma mortality rates is necessary to confirm these trends.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jdv.16983","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T18:31:59Z","timestamp":1602181919000},"page":"884-891","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Cutaneous malignant melanoma mortality in Spain from 1979 to 2018. Trends and new perspectives in the immunotherapy era"],"prefix":"10.1111","volume":"35","author":[{"given":"A.J.","family":"Dur\u00e1n\u2010Romero","sequence":"first","affiliation":[{"name":"Dermatology Department Hospital Universitario Virgen del Roc\u00edo Sevilla Espa\u00f1a"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0156-381X","authenticated-orcid":false,"given":"M.","family":"Send\u00edn\u2010Martin","sequence":"additional","affiliation":[{"name":"Dermatology Department Hospital Universitario Virgen del Roc\u00edo Sevilla Espa\u00f1a"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Conejo\u2010Mir","sequence":"additional","affiliation":[{"name":"Dermatology Department Hospital Universitario Virgen del Roc\u00edo Sevilla Espa\u00f1a"},{"name":"School of Medicine Sevilla University Sevilla Espa\u00f1a"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6843-5877","authenticated-orcid":false,"given":"J.J.","family":"Pereyra\u2010Rodriguez","sequence":"additional","affiliation":[{"name":"Dermatology Department Hospital Universitario Virgen del Roc\u00edo Sevilla Espa\u00f1a"},{"name":"School of Medicine Sevilla University Sevilla Espa\u00f1a"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,11,29]]},"reference":[{"key":"e_1_2_6_2_1","unstructured":"Cancer.org[Internet].Atlanta GACS c2020[cited 2020 A 23]. URLhttps:\/\/www.cancer.org\/es\/cancer\/cancer\u2010de\u2010piel\u2010tipo\u2010melanoma\/acerca\/estadisticas\u2010clave.html(last accessed 23 April 2020)."},{"key":"e_1_2_6_3_1","unstructured":"Global Cancer Observatory[Internet].Lyon FIA for R on CWHO c2018\u201320[cited 2020 A 23]. URLhttp:\/\/gco.iarc.fr\/today\/online\u2010analysis\u2010table?v=2018&mode=cancer&mode_population=continents&population=900&populations=900(last accessed 23 April 2020)."},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2018.07.005"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15565"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.27616"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23086"},{"key":"e_1_2_6_8_1","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios[Internet]. Madrid S c2017 [cited 2020\/08\/08]. URLhttps:\/\/cima.aemps.es\/cima\/publico\/home.htm(last accessed 8 August 2020)."},{"key":"e_1_2_6_9_1","unstructured":"BIFIMED: Buscador de la Informaci\u00f3n sobre la situaci\u00f3n de financiaci\u00f3n de los medicamentos.Ministerio de Sanidad Consumo y Bienestar Social[Internet]. [cited 2020\/08\/08]. URLhttps:\/\/www.mscbs.gob.es\/profesionales\/medicamentos.do?(last accessed 8 August 2020)."},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1503093"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2013.07.001"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06517.x"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23118"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16777"},{"key":"e_1_2_6_15_1","volume-title":"Revision of the European Standard Population: report of Eurostat\u2019s task force\u202f: 2013 edition","author":"Pace M","year":"2013"},{"key":"e_1_2_6_16_1","unstructured":"National Cancer Institute.Joinpoint regression program version 4.2.0.2 statistical methodology and applications branch surveillance research program national cancer institute 2015. No Title."},{"key":"e_1_2_6_17_1","first-page":"e9977","article-title":"An R package for fitting age, period and cohort models","volume":"11","author":"Decarli A","year":"2014","journal-title":"Epidemiol Biostat Public Heal"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780010306"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-7310(05)73105-7"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12236"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2015.12.008"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.07.039"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/CEJ.0000000000000306"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0213-9251(02)72640-3"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-7310(05)73073-8"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09779-9"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjps.2006.05.008"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2009.05.001"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2018.07.015"},{"key":"e_1_2_6_30_1","doi-asserted-by":"crossref","DOI":"10.7812\/TPP\/19.093","article-title":"Immunotherapy outcomes in advanced melanoma in relation to age","volume":"24","author":"Joshi K","year":"2020","journal-title":"Perm J"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2019-0094"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.5904"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2020.305567"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19010"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2013.02.003"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-7310(08)74717-3"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2004.06.003"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2012-001758"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.11.019"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2007.02517.x"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2017.12.024"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.16983","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jdv.16983","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.16983","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T17:12:38Z","timestamp":1693588358000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.16983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,29]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1111\/jdv.16983"],"URL":"https:\/\/doi.org\/10.1111\/jdv.16983","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,29]]},"assertion":[{"value":"2020-05-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}